We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Dr Martens plc (DOCS) ORD GBP0.01

Sell:194.90p Buy:195.30p 0 Change: 1.30p (0.66%)
FTSE 250:0.42%
Market closed Prices as at close on 25 May 2022 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:194.90p
Buy:195.30p
Change: 1.30p (0.66%)
Market closed Prices as at close on 25 May 2022 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:194.90p
Buy:195.30p
Change: 1.30p (0.66%)
Market closed Prices as at close on 25 May 2022 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Dr. Martens plc is a United Kingdom-based company that designs, develops, procures, markets, sells and distributes footwear, under the Dr. Martens brand. The Company operates through three reporting segments: Europe, the Middle East and Africa (EMEA), Americas and Americas and Asia-Pacific (APAC). Its product categories include Originals, Fusion, Kids, Casual and Accessories. The Originals category comprises boots, shoes and loafers and also included within the Originals category is the Made in England range. The Fusion category comprises platform boots and shoes, sandals, heels and refined take downs of the Originals. Within the Kids category is the mini-me range, which includes Originals, Fusion and Casual collections. It offers various accessories, such as shoe care, laces and socks, leather bags and small leather items. It operates in over 60 countries globally, through a range of modes: directly operated stores and ecommerce sites, wholesale partners and distributors.

Contact details

Address:
28 Jamestown Rd, Camden
LONDON
NW1 7BY
United Kingdom
Telephone:
+ (0)
Website:
https://www.drmartensplc.com/

Important dates

Future events
Final results 01 June 2022 01/06/22
Past events
Interim dividend payment date 04 February 2022 04/02/22
Trading Announcement 27 January 2022 27/01/22
Interim ex-dividend date 13 January 2022 13/01/22
Interim results 09 December 2021 09/12/21
AGM 29 July 2021 29/07/21
Trading Announcement 29 July 2021 29/07/21
Annual report 01 July 2021 01/07/21
Final results 17 June 2021 17/06/21

General stock information

EPIC:
DOCS
ISIN:
GB00BL6NGV24
Market cap:
£1.95 billion
Shares in issue:
1.00 billion
Sector:
No specific Industry
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
FTSE 250,FTSE 350,FTSE All Share

Key personnel

  • Kenny Wilson
    Chief Executive Officer, Executive Director
  • Jon Mortimore
    Chief Financial Officer, Executive Director
  • Emily Reichwald
    General Counsel, Company Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.